5 Best Biotech Companies to Watch
The Silicon Review
| Company | Management | Description |
| Creatv Bio creatvbio.com |
Dr. Cha-Mei Tang Founder, President & CEO |
Creatv Bio is recognized for pioneering next-generation cancer diagnostics through its proprietary LifeTracDx® liquid biopsy. Advanced blood-based technologies are used to detect and monitor cancer with high precision. Groundbreaking discoveries, such as CAMLs, have been leveraged to enhance early detection and treatment response evaluation. |
| Antharis antharistherapeutics.com |
Raphael Ribeiro Pinaud PhD, MBA, CEO & Chairman |
Antharis is positioned as a frontrunner in antibody-based immunotherapies, serving patients facing devastating and underserved diseases. Breakthrough monoclonal and bispecific antibody platforms were developed to harness the immune system with unprecedented precision and therapeutic relevance. Advanced scientific methodologies and disease-informed target discovery are leveraged to deliver next-generation treatments for cancer and other critical conditions. |
| Mission Bio missionbio.com |
Brian Kim Chief Executive Officer |
Mission Bio is recognized for delivering the Tapestri® single-cell multi-omics platform, empowering researchers and clinicians to decode tumor heterogeneity with unparalleled resolution. Comprehensive DNA, CNV, and protein insights are provided to accelerate precision-medicine discovery, streamline drug development, and illuminate mechanisms of resistance across oncology. |
| Gubra gubra.dk |
Henrik Blou Chief Executive Officer |
Founded in 2008, Gubra has been recognized as a Danish biotech company specializing in preclinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases. The company has been known for its AI-driven platforms and strategic collaborations, contributing significantly to advancements in therapeutic development. |
| Foundation Medicine Foundationmedicine.com |
Dan Malarek Chief Executive Officer |
Foundation Medicine is positioned as a trailblazer in comprehensive genomic profiling, transforming cancer care through data-driven precision diagnostics. Its solutions have been adopted globally to inform and personalize oncology treatment decisions. |
MOST VIEWED ARTICLES
RECOMMENDED NEWS
TOP NEWS
YOU MAY ALSO LIKE
